A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/1992
12/23/1992	EP0519516A1 Penem derivatives
12/23/1992	EP0519463A1 Synthetic, catalytic oligonucleotides
12/23/1992	EP0519458A1 Feed additive for livestock and feed for livestock
12/23/1992	EP0519449A1 2-Amino-4-aryl thiazoles with antiasthmatic and antiinflammatory activities on the respiratory tract
12/23/1992	EP0519434A2 Heterocyclic compounds with renin inhibiting properties, process for their preparation and their use
12/23/1992	EP0519433A1 Compounds with renin-inhibiting properties, process for their preparation and their use
12/23/1992	EP0519428A2 Cyclodextrin composition
12/23/1992	EP0519365A1 Compositions for oral administration containing pantoprazole
12/23/1992	EP0519353A2 Indolizin derivatives, process for their preparation and pharmaceutical composition containing them
12/23/1992	EP0519351A2 Megestrol acetate formulation
12/23/1992	EP0519307A2 Tetracyclic Imidazodiazepines
12/23/1992	EP0519291A1 Amino-methyl substituted 2,3-Dihydropyrano (2,3-b) pyridines, process for their preparation and their use in medicines
12/23/1992	EP0519290A1 Use of 6(7)-amino-substituted-5,8-quinolinediones to combat endoparasites, new 6(7)-aminosubstituted 5,8-quinolinediones and processes for their preparation
12/23/1992	EP0519144A1 New galenic process for omeprazole containing pellets
12/23/1992	EP0519119A1 Polyamides bearing functionalized side chains useful as water soluble hypolipidemic agents
12/23/1992	EP0519099A1 Direct compression cyclophosphamide tablet
12/23/1992	EP0519023A1 Folded sheet means
12/23/1992	EP0518961A1 Derivatives of glycinamide, their preparation and medicaments containing them
12/23/1992	EP0518951A1 Phenyl butyl nitrone compositions for prevention of gastric ulceration
12/23/1992	EP0518943A1 Mercaptoacyl aminolactam endopeptidase inhibitors
12/23/1992	EP0518939A1 Antiarrhythmic agents
12/23/1992	EP0518930A1 Cyclodextrin compositions and methods for pharmaceutical and industrial applications
12/23/1992	EP0460080B1 Orally administerable calcium supplement for cattle
12/23/1992	EP0439450B1 Pharmaceutical composition
12/23/1992	EP0310648B1 Condensation products of 2,2,4-trimethyl-1,2-dihydro-quinoline and oxo compounds and derivatives thereof
12/23/1992	EP0256137B1 Bis-dioxopiperazine derivatives
12/23/1992	EP0241533B1 Rapid acting intravenous emulsions of omega-3 fatty acid esters
12/23/1992	CN1067245A Processes for diastereoselective synthesis of nucleosides
12/23/1992	CN1067244A Pyrrolidones
12/23/1992	CN1067243A Methods for preparation and use of 1 alpha, 24 dihydroxy vitamin d2
12/23/1992	CN1019578B Process for preparation of quinolinecarboxylic acid derivatives
12/23/1992	CN1019577B Enol ethers of 6-chloro-4-hydroxy-2-methyl-n-(2-pyridyl)-2h-thieno (2,3-e)-1,2-thiazine-3-carboxamide 1,1-dioxide, process for their preparation and their use
12/23/1992	CN1019576B Preparation of 3,4-dihydro-2-alkyl-3-oxo-n-aryl-2h-(1) benzothieno (3,2-e)-1,2-thiazine-4-carboxamide-1,1-dioxides
12/23/1992	CN1019573B Process for preparing nitroheterocyclic alkane derivatives
12/23/1992	CN1019571B Process for preparation of diphenylpropylamine derivatives and their salts
12/23/1992	CN1019545B Process for preparing pharmaceutical composition ( comprising quinoline derivatives) for treatment of cardiac arrhythmias
12/23/1992	CN1019544B Pharmaceutical composition for piperidinoalkanol derivatives
12/23/1992	CA2524168A1 Oral-administration forms of a medicament containing pantoprazole
12/23/1992	CA2296897A1 Piperidine derivates having anxiolytic effect
12/23/1992	CA2111699A1 Ocular compositions containing steroids and their use for the glaucoma treatment
12/23/1992	CA2111472A1 Antisense oligonucleotide inhibition of the ras gene
12/23/1992	CA2111469A1 New selective aromatase inhibiting 4(5)-imidazoles
12/23/1992	CA2111459A1 Novel 3-fused pyridiniummethyl cephalosporins
12/23/1992	CA2111442A1 Aminoalkyl-substituted 2-amino-5-mercaptothiadiazoles the preparation and use thereof
12/23/1992	CA2111441A1 Aminoalkyl-substituted thiazolin-2-ones, the preparation and use thereof
12/23/1992	CA2111440A1 Aminoalkyl-substituted 2-amino-1,3,4-thiadiazoles, the preparation and use thereof
12/23/1992	CA2111439A1 Aminoalkyl-substituted 5-mercaptothiazoles, the preparation and use thereof
12/23/1992	CA2111338A1 New compounds and compositions useful as antifungal and antimycobacterial agents
12/23/1992	CA2111231A1 Acylated heparins as inhibitors of the replication of retroviruses
12/23/1992	CA2111003A1 Non-chlorofluorocarbon aerosol formulations
12/23/1992	CA2110997A1 Methods for the synthesis of monofucosylated oligosaccharides terminating in di-n-acetyllactosaminyl structures
12/23/1992	CA2110942A1 Imidazo¬1,5-a\|quinoxalines
12/23/1992	CA2110707A1 Immunosuppressive and tolerogenic oligosaccharide modified lewis x and lewis a compounds
12/23/1992	CA2110577A1 Immunomodulatory azaspiranes
12/23/1992	CA2110495A1 Immunosuppressive and tolerogenic oligosaccharide derivatives
12/23/1992	CA2103377A1 Selective inhibition of leukemic cell proliferation by bcr-abl antisense oligonucleotides
12/23/1992	CA2071677A1 7-isoindolinyl-quinolone- and -naphthyridonecarboxylic acid derivatives
12/22/1992	WO1993000345A1 Penem derivatives
12/22/1992	WO1993000005A1 Method for inactivating pathogens in a body fluid
12/22/1992	US5173511 Administering to reduce the discomfort associated with asthma
12/22/1992	US5173509 Suramin and active analogues thereof in the treatment of hypercalcemia
12/22/1992	US5173508 Treating myocardial anoxia, cardiac antiischemic and antiarrhythmia agents and congestive heart failure
12/22/1992	US5173507 Synergistic mixture of PGF2a and PGE2; side effect reduction;
12/22/1992	US5173506 N-(mercaptoalkyl)ureas and carbamates
12/22/1992	US5173505 Anti-neoplastic, anti-viral and ribonucleotide reductase activity affecting pharmaceutical compositions and methods of treatment
12/22/1992	US5173502 For treating depression, hypertension, parkinson*s disease, asthma, convulasions, platelet aggregation of metabolic disorders
12/22/1992	US5173498 Substituted 3-thia- and 3-oxa-alkylflavones, a process for their preparation, the use thereof, medicaments based on these compounds and intermediates
12/22/1992	US5173496 Antiinflammatory agents
12/22/1992	US5173494 Specific inhibition of angiotensin-II binding to angiotensin-II receptor subtype-2
12/22/1992	US5173493 For treatment or prevention of nausea or vomiting
12/22/1992	US5173491 Pharmaceutical compositions and a method for the treatment of memory disorders, intellectual disorders of ageing and alzheimer's disease
12/22/1992	US5173490 Benzisoxazole and benzisothiazole compounds
12/22/1992	US5173489 α,α-disubstituted aromatics and heteroaromatics as cognition enhancers
12/22/1992	US5173488 Stable injectable pharmaceutical formulation for folic acid and leucovorin salts and method
12/22/1992	US5173487 Mevinic acid derivatives
12/22/1992	US5173486 Dibenz[b,f][1,4]oxazepin-11(10H)-ones for multidrug resistance reversing agents
12/22/1992	US5173483 Administering anti-progestomimetic compound
12/22/1992	US5173482 A dioxoalkyl phosponate or a proline-modified polyoxyethylene glycol derivative; autoimmune diseases; organ transplants; immunoassay
12/22/1992	US5173304 Agents for the treatment of severe pain and preparation of said agents
12/22/1992	US5173298 Nonaqueous fluorinated drug delivery vehicle suspensions
12/22/1992	US5173287 Carboxylic acid compositions
12/22/1992	US5172481 Electronic inclinometer
12/22/1992	CA2158009A1 Anti-viral compounds and processes for production of anti-viral compounds
12/22/1992	CA2088913A1 Penem derivatives
12/22/1992	CA2071744A1 Compounds with renin-inhibiting properties, a process for the preparation thereof and the use thereof
12/22/1992	CA2071743A1 Heterocyclic compounds with renin-inhibiting properties, a process for the preparation thereof and the use thereof
12/22/1992	CA2071690A1 Derivatives of (hetero) aromatic ethers and thioethers having antihyperlipidemic activity, process for their preparation and pharmaceutical compositions containing them
12/22/1992	CA2071566A1 6(7)-amino-substituted quinoline-5,8-quinones for combating endoparasites, new 6(7)-amino-substituted quinoline-5,8-quinones and processes for their preparation
12/22/1992	CA1311767C 5-substituted ornithine derivatives
12/22/1992	CA1311762C 5-phenyl-1,2,3a,4,5,9b-hexahydro-3h-benz [e] indoles, preparation and usethereof as drugs
12/22/1992	CA1311760C Pyrazoline derivatives and agents for treating cerebrovascular diseases containing the same as active ingredient
12/22/1992	CA1311757C Acetylenes disubstituted with a heteroaromatic group and a tetralin group having retinoid like activity
12/22/1992	CA1311755C 4-(aroylamino)piperidinebutanamide derivatives
12/22/1992	CA1311754C Thiazole compounds, processes for the preparation thereof and pharmaceutical composition comprising the same
12/22/1992	CA1311752C Substituted pyrido (2,3-b)(1,4)benzodiazepin-6-ones, processes for theirpreparation and medicaments containing these compounds
12/22/1992	CA1311749C 17.alpha.-(ARYLOXY OR ALKOXY) ANDROSTENES
12/22/1992	CA1311687C Dosage form for delivering diltiazem
12/22/1992	CA1311683C Process for the preparation of a composition inhibiting or destructing at least one living unicellulary organism containing quaternary ammonium fluorideand process for the preparation of this salt
12/21/1992	CA2071803A1 4a-substituted avermectin derivatives
12/21/1992	CA2071802A1 Composition for slowing the rate of falling hair and inducing and stimulating hair growth, containing pyrimidines n-oxyde trisubstituted in 2,4 and 6 with an amine functionality or their sulfoconjugated derivatives, novel pyri idines n-oxyde compounds or their sulfoconjugated derivatives

1 ... 7225 7226 7227 7228 7229 7230 7231 7232 7233 7234 7235 7236 7237 7238 7239 7240 7241 7242 7243 7244 7245 ... 7860